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embryonic development has been well characterized; Sox9 expression differentiates cells
derived from all three germ layers into a large variety of specialized tissues and organs. How-
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tion of Sox9 has been implicated in various congenital and acquired diseases, including fibrosis
and cancer. This review provides a summary of the various roles of Sox9 in cell fate specifica-
tion, stem cell biology, and related human diseases. Ultimately, understanding the mecha-
nisms that regulate Sox9 will be crucial for developing effective therapies to treat disease
caused by stem cell dysregulation or even reverse organ damage.
Copyright ª 2014, Chongqing Medical University. Production and hosting by Elsevier B.V. All
rights reserved.of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center, 5841
cago, IL 60637, USA. Tel.: þ1 773 702 5263; fax: þ1 773 834 4598.
cago.edu (R.C. Haydon).
f Chongqing Medical University.
14.09.004
ng Medical University. Production and hosting by Elsevier B.V. All rights reserved.
150 A. Jo et al.IntroductionStem cells are undifferentiated biological cells that can
self-renew or differentiate into one or more mature cellular
lineages.1 In mammals, stem cells can differentiate into
specialized cells of every germ layerdectoderm, endoderm
and mesodermdin a developing embryo, but can also
maintain the normal turnover of regenerative tissues, such
as in skin and intestines.1 In adult organisms, stem and
progenitor cells are kept in pools known as “niches,” which
act as a repair system to replenish damaged tissues.2 A
stem cell’s decision between self-renewal and differentia-
tion is a tightly regulated process that requires expression
of cell type-specific transcription factors. Over the last few
years, several such molecules have been implicated in stem
cell biology, although their versatile functions in different
tissues remain to be fully elucidated.
Sox family proteins are a group of transcriptional regu-
lators containing a high mobility group (HMG) domain that is
highly conserved.3 The HMG domain was first identified in
Sry, a crucial factor involved in mammalian male sex
determination.3,4 In general, proteins containing an HMG
domain with 50% or higher amino acid similarity to the HMG
are referred to as Sox proteins (Sry-related HMG box).
Around 20 Sox proteins to this date has been identified in
mice and humans, and are grouped A through H based on
the structural homology outside of their HMG boxes.
Notably, Sox-like proteins are identified in invertebrate
lineages and in the unicellular organisms, suggesting that it
is evolutionarily conserved.5 Early insights into the function
of Sox factors have involved cell fate determination during
development, although recent findings reveal its crucial
role in establishing and maintaining stem and progenitor
cell pools.
In this review, we confine our discussion to one of the
well-characterized SoxE proteins, Sox9. After discussing
multiple levels of regulation and mechanisms, we review
the versatile functions of Sox9 in germ layers and adult
tissues as a stem cell regulator. We then discuss its function
in disease pathogenesis while highlighting the Sox9-related
pathology of fibrosis and cancer.
Molecular characteristics of Sox9
Structural domains of Sox9
Research on Sox9 began with its seminal discovery as the
gene underlying campomelic dysplasia (CD), a hap-
loinsufficiency disorder characterized by defective chon-
drogenesis and a high proportion of male-to-female sex
reversals in XY males.6 Along with Sox8 and 10, Sox9 belongs
to the SoxE subgroup, and, characteristic of all Sox proteins,
contains the HMG domain which induces significant bending
at the consensus-binding motif (A/TA/TCAAA/TG) by form-
ing an L-shaped complex in the minor groove of DNA.3
Members of the SoxE subgroup share regions of significant
homology outside the HMG domain, and constitute two
additional functional domains: a self-dimerization domain
and a transactivation domain at the C-terminus (Fig. 1).3,7
A recurring theme among Sox proteins, Sox9 shares
functions redundant within the SoxE subgroup. This is welldemonstrated in knockout mutants, where individual Sox9
mutants often have a starkly less severe phenotype than
double or triple SoxE mutants. For instance, separate de-
letions of either Sox9 or Sox10 retain normal formation of
oligodendrocytes, whereas the deletion of both results in
widespread apoptosis.8 However, depending on the tissue in
question, the individual contribution of each member may
differ temporally and in the amount of expression. While
replacing Sox8 with Sox10 resumes normal development of
glial cells and neurons in the sensory and sympathetic parts
of the peripheral nervous system, only Sox10-deficient mice
show defective melanocyte development.9 Another report
showed that, despite functional redundancy of Sox8 and
Sox10 in oligodendrocyte development, Sox8 expression
levels are significantly lower than those for Sox10.10
Posttranscriptional regulation of Sox9
Sox9 is subject to context-dependent regulation at multiple
levels. One type of regulation is posttranscriptional modi-
fication, which modulates the stability, intracellular local-
ization, and the overall activity of Sox9.11e13
Phosphorylation by protein kinase A (PKA) enhances DNA-
binding affinity of Sox9 and leads to its translocation into
the nucleus in testis cells.14 Interestingly, this same event is
also required in the neural crest (NC) cells for the SoxeSnail
interaction during NC delamination, and is necessary for
parathyroid hormone-related peptide (PTHrP)-mediated
regulation of chondrocyte maturation.11,12
SUMOlaytion, or post-transcriptional regulation by small
ubiquitin-related modifier, has also been noted to influence
Sox9-dependent transcription, although context determines
whether it is activational or repressive. For example,
co-transfection with a SUMO-expressing vector enhances
the transcriptional activity of Sox9-dependent Col2a1 re-
porter.15 On the other hand, covalent attachment of SUMO-1
to Sox9 by gene fusion dramatically compromises its tran-
scription activity on the reporter gene.16 In some situations,
SUMOlyation of Sox9 acts as a switch to drive tissue differ-
entiation one way or another. In Xenopus, non-SUMOlyated
SoxE proteins promote NC development, whereas SUMOy-
lated SoxE proteins promote inner ear development.13
MicroRNAs, small noncoding RNAs that control gene
expression, inhibit Sox9 expression in lung development,
during chondrogenesis and neurogenesis, and in developing
mouse ovarian cells.17e20 The ubiquitin-proteasome
pathway represses Sox9 transcriptional activity by degrad-
ing Sox9 in hypertrophic chondrocytes.21 The regions of
Sox9 subject to these posttranslational modifications are
shown in Fig. 1.
The Sox9-partner complexes
Sox proteins generally exhibit their gene regulatory func-
tions by forming complexes with partner transcriptions
factors, which can be transcription factors from another
protein family, homologous Sox protein or heterologous
Sox protein (Fig. 2A). Binding of either a single Sox protein
or the partner protein alone to a DNA site does not
elicit transcriptional activity.22 Target genes often have
binding sites for a partner protein adjacent to a functional
Figure 1 Schematic structures of SoxE proteins. In all SoxE proteins, the dimerization domain (DIM) precedes the DNA-binding
high mobility group (HMG) domain and two separate transactivation domains are located in a central position (K2) and at the C-
terminus (TA). For Sox9, two independent nuclear localization sequences (NLS) and the nuclear export sequences (NES) in the HMG
domain, phosphorylation sites (red), and ubiquination/sumolyation sites (blue) are highlighted.3,7.
Sox9 in development and diseases 151Sox-binding site, as in the case with the homodimer-binding
sequences on the enhancer regions of chondrogenic
genes.22,23 It is inferred that a Sox-partner complex forms
first, and then recognizes target DNA sites as a complex.23
Whether Sox9 elicits transcriptional activation or
repression depends on the target site, partner factors, and
the subsequent recruitment of either co-activators or re-
pressors (Fig. 2B). During hypertrophic chondrocyte matu-
ration, Sox9 recruits Gli protein as the partner factor, and
the complex represses the gene transcription of Col10a1,
the gene that is required for chondrocyte maturation.24 On
the other hand, a Sox9 dimer recruits SoxD (Sox5/6) dimersFigure 2 Regulation by Sox9-partner complexes. A) Sox9 require
repression.22,23 B) Sox9 can function to activate or repress transcrip
it is expressed. During earlier chondrogenesis, Sox9-Gli2/3 complex
activates Col2a1.24,25 C) Sox-partner complexes form a feedforward
SRY cooperatively upregulate Sox9 and then, together with Sf1, Soto activate Col2a1, which is required for chondrogenic
differentiation and extracellular matrix (ECM) deposition.25
One of the advantages of Sox-partner interactions is that
they allow for stepwise progression of developmental pro-
cesses (Fig. 2C). For instance, Sox-partner complexes can
activate a second Sox gene that acts downstream,
employing the same partner factor. In male gonad, Sry and
steroidogenic factor-1 (Sf1, also known as AD4BP) form a
complex to induce Sox9 expression, and this newly tran-
scribed Sox9 partners with Sf1 to promote subsequent
development processes. This self-pertetuating pathway
helps maintain continued Sox9 expression, even after thats a binding partner to elicit either transcriptional activation or
tion, depending on the partner factor and on the tissue in which
represses Col10a1 while the “sox trio,” Sox9-Sox5/6 complex,
, self-reinforcing pathway. During male gonad genesis, Sf1 and
x9 maintains its own expression.26.
Figure 3 Sox9 expression in pluripotent, fetal, and adult
stem and progenitor cells. Sox9 is expressed throughout
development, initially in pluripotent founder cells and subse-
quently in ectodermal, endodermal, and mesodermal de-
rivatives. Sox9 expression is maintained in fetal and adult
tissues derived from Sox9þ fetal progenitor cells and also in
differentiated cells in some cases.26e32,39,40,42e101.
152 A. Jo et al.of SRY has ceased.26 Knowing how such binding partners
work is important for the ensuing discussion on diverse
functions of Sox9 in different organs and tissue.
The roles of Sox9 in mesoderm development
Sox9 in chondrogenesis and skeletal development
During chondrogenesis and endochondral ossification,
mesenchymal cells condense and differentiate into chon-
drocytes in a pattern that will define the eventual shape of
the skeletal elements.27,28 In this process, Sox9 is essential
for mesenchymal condensation prior to chondrogenesis,
and for inhibiting hypertrophy. Inactivation of Sox9 in
chondrocytes at different stages of differentiation suggests
that its expression is essential for the survival of chon-
drocytes to progress to hypertrophy.25 Upon hypertrophy,
the chondrocytes down-regulate Sox9 expression to allow
for vascular invasion and bone marrow formation.29
Sox9 activates many genes in proliferating chondrocytes,
including the ECM genes Col2a1, Col9a1, Col11a2 and Acan
(aggrecan).30 Sox9 directly trans-activates Col2a1, the
collagen II gene that is expressed most strongly in prolifer-
ating chondrocytes, in vivo via a conserved enhancer
sequence within the first intron.31 In addition to trans-
activating genes expressed in non-hypertrophic chon-
drocytes, Sox9 directly represses expression of Col10a1 just
prior to the onset of hypertrophy.24 Given the importance of
Sox9 in chondrogenesis, it was reported that Sox9 may be
explored as an important biofactor to treat or prevent
intervertebral disc degeneration.32 The versatile functions
of Sox9 in developmental and homeostatic processes are
shown in Fig. 3, and the related signaling pathways are
summarized in Table 1.
Sox9 in male gonad genesis
In mammals, Sry on the Y chromosome initiates the testis
differentiation program, and Sox9 carries out the process
by specifying the Sertoli cell lineage. The role of Sox9 in
testis formation and subsequent sex determination was first
recognized by genetic analysis of human campomelic
dysplasia, in which about 75% of XY males with one mutant
Sox gene exhibit male-to-female sex reversal.42 Similarly,
duplicate Sox9 genes have been linked with male gonad
genesis even in karyotypically XX subjects.43 In the male
gonad, the combination of Sry and Sf1 initiates Sox9
expression, which is continued even after Sry expression
disappears in positive auto-regulatory feedback loops.26 In
the female gonad, on the other hand, Sox9 expression dis-
appears due to the lack of Sry expression.42 Sox9-axis
signaling induces ovaryetestis transition in zebrafish, sug-
gesting that its role in sex reversal is conserved.44
To complete gonad genesis, Sox9 recruits different
binding partners to elicit two separate trans-activating
functions.45,46 In the former, Sox9 homodimerizes to acti-
vate prostaglandin D synthase (Ptdgs), the gene that en-
codes an enzyme responsible for producing prostaglandin
D2 (Pgd2). Pgd2 then recruits cells of the supporting lineage
to become Sertoli cells.45 In the latter, the Sox9-Sf1 com-
plex upregulates anti-Mullerian hormone (AMH) in a cyclicAMP-dependent manner, which inhibits the development of
the female Mullerian ducts.46 Sox8 is also important for
testis cord differentiation. In mice, an experiment using
Sox9 conditional knockout on a Sox8 mutant background
showed that Sox8 expression follows that of Sox9, being
required for the maintenance of testicular function at a
later stage.47 However, the regulation of AMH by SoxE
proteins is not conserved in mice and chickens. In the
developing chicken, AMH is expressed one day before Sox9,
suggesting that another AMH activating factor exists, and
Sox8 is expressed at similar levels in both sexes during the
sex-determining period.48,49
Sox9 in other mesoderm tissues: cardiac valves/
septa, and pyloric sphincter
In the heart, Sox9 is highly expressed in cardiac cushion
cells, and is required for the normal development of valves
and septa.50 Furthermore, Sox9 is required for precursor
cell expansion and ECM organization during mouse heart
development.51 In these instances, Sox9 seems to promote
epithelial-mesenchymal transition (EMT) after delamina-
tion and initial migration of endocardial endothelial cells.50
Given the significance of EMT in fibrosis and cancer prog-
nosis, there is much consideration about the relevance of
Sox9 in these diseases.52
In the pyloric sphincter, a structure that demarcates the
stomach from the duodenum, Sox9 is important in speci-
fying its epithelium. Misexpression of Sox9 in the mesoderm
of the stomach inhibits the differentiation of the gastric
Table 1 Signaling pathways that regulate Sox9 during development and in human diseases.
Key factors Mesoderm Ectoderm Endoderm
Hh Sonic hedgehog (Shh) upregulates
Sox9 to generate chondrogenic
precursors33; Indian hedgehog (Ihh)
upregulates Sox9 for proliferation
and maturation of chondrocytes34
N/A Upregulates Sox9 to modulate
OPN in liver fibrosis35
Wnt/b-catenin Wnt5 upregulates Sox9 during early
stages of chondrogenesis and inhibits
it during chondrocyte maturation36,37;
Sox9 interacts with b-catenin to inhibit
its transcription38
Phosphorylates Sox9
for NC cell
delamination along
with BMP12
Upregulates Sox9 for intestinal
SC proliferation and Paneth
cell differentiation41; upregulates
Sox9 to inhibit villus maturation96
Notch Inhibits Sox9 expression in vivo and
in vitro102; upregulates Hes1 and Hey1,
which compete for Sox9 binding of the
Col2a1 enhance to prevent
Sox9-mediated activation103
Induces Sox9 expression
for stem cell
maintenance and
strogliogenesis55;
regulates Sox9 and
Hes1 in the developing
and mature retina67
Regulates Sox9 in the liver
development81; regulates Sox9 in
dose-dependent manner to induce
Ngn3 for pancreatic endocrine and
ductal cell differentiation75
TGF-b Upregulates Sox9 and Smad3,36 and
activates Sox9 in vitro to mediate
chondrogenic commitment104
N/A Induces Sox9 expression to inhibit
hepatogenic differentiation
potential of ADHLSCs105
NFkB Reduces Sox9 activity and cartilage
gene expression by converging with
RAR pathway106;
RelA activates Sox9 for chondrogenic
differentiation107
N/A Epigenetically regulates Sox9 in
pancreatic cancer stem cells108
BMP BMP2 induces chromatin remodeling,
and modifies the Sox9 promoter109;
BMP4 upregulates Sox9 in semilunar
valve cells110; upregulates Sox9 and
Nkx2.5 to determine the pyloric
sphincter epithelium54
Phosphorylates Sox9 with
Wnt for NC cell
delamination along
with Wnt12
Induces Sox9 expression in
endoderm and pancreatic
lineage differentiation along with
Activin and FGF pathway111
Fgf Fgf9 upregulates Sox9 to induce
endochondral ossification112
Activates Sox9-Sox10 pathway
for branching morphogenesis
of mouse ocular glands113;
upregulates Sox9140
Creates feed-forward loop to
maintain pancreatic organ
identity114
Sox9 in development and diseases 153epithelium into pyloric sphincter-like epithelium.53 Simi-
larly, another finding showed that Sox9 is regulated by BMP
signaling in the pyloric sphincter, a pathway involved in
epithelial-mesenchymal interactions for organ-specific
morphogenesis of the gut tube.54
The roles of Sox9 in ectoderm development
Sox9 in neural stem cells (NSCs), gliogenesis, and
neural crest (NC) stem cells
Sox9 regulates wide-ranging aspects of development in the
central nervous system (CNS) and in neural crest (NC). Gain-
and loss-of-function studies indicated that, during the CNS
development, Sox9 is necessary and sufficient to initiate
the induction of embryonic and adult neural stem cells.55,56
Moreover, Sonic Hedgehog (SHH) induces Sox9 expression,
which in return stimulates precocious generation of NSCs.56
In the CNS, Sox9 drives the differentiation program away
from neurogenesis and towards gliogenesis.8,55,57,58 Sox9
expression in NSCs continues in glial cells, but not inneurons. A study using Cre/loxP recombination system that
ablates Sox9 expression showed that, in the developing
spinal cord, Sox9 elicits the specification of myelin-forming
oligodendrocytes and astrocytes, the two main types of
glial cells in the CNS.59 For glial initiation, Sox9 recruits the
transcription factor NFIA as a binding partner to co-regulate
migratory and metabolic genes in astrogliogenesis, such as
Apcdd1 and Mmd2.57 Importantly, Sox9 and Sox10 play
redundant functions in survival and migration of oligoden-
drocyte precursors.8 Notch1 seems to be a part of the up-
stream pathway in astrogliaogenesis and stem cell
maintenance, as demonstrated in the studies involving
transient activation and knockdown of Notch1 during neu-
roectodermal differentiation.55
Neural crest is a population of multipotent stem cells
derived from dorsal neural folds at the border between
neural and non-neural ectoderm in the vertebrate embryo.
Once induced, neural crest cells undergo epithelial-
mesenchymal transition (EMT), delaminate from the
neural tube, and migrate into the periphery to give rise
to multiple differentiated cell types.60 Sox9 plays a crucial
role in NC development, and is required for NC progenitor
154 A. Jo et al.specification. Forced expression of Sox9 promotes neural
crest-like properties in neural tube progenitors at the
expense of CNS neuronal differentiation, and inmigratory NC
cells, SoxEexpression guidesNC stemcells towards a glial cell
fate.61 As in the heart, Sox9 is important for EMT (Fig. 4A). In
avian neural tube, Sox9 is essential for BMP signal-mediated
induction of Snail2 and subsequent EMT, and cotransfection
of Sox9 and Snail2 is sufficient to induce ectopic EMT.12,39 In
Xenopus, however, Sox9 is required only for neural crest
specification but not migration,40 implying that the fates of
NC progenitors are not conserved between species.
Sox9 in hair follicle stem cells (HF-SCs)
The function of Sox9 in HF-SCs was first noted in the HF
bulge, an adult-specific stem cell niche that provides an
appropriate microenvironment to preserve the proliferative
potential of hair follicles.62 Although the study by Vidal
et al in 2005, which will be discussed in the later section,
established the importance of HF-SCs in adult life, whether
SCs exist or function earlier during development was largely
unknown.63 However, the findings by Nowak et al in 2008
demonstrated that HF-SCs are formed at earlier stages and
that the niche formation dependent on Sox9. In this newer
study, embryonic ablation of Sox9 using Sox9-Cre genetic
marking and K14-Cre led to a reduced number of Sox9-
expressing cells in all skin epithelial lineages. In the
absence of early SCs, hair follicle and sebaceous gland
morphogenesis is blocked and epidermal wound repair is
compromised.64Figure 4 EMT induction by Sox9 in acquired diseases. A) Sox9 is
crest delamination during development.12,39,40 B) Sox9 plays a role i
may be related to fibrosis. C) Sox9 is important for ECM deposition
invasive metastasis.Sox9 in other ectodermal tissues: retinal
progenitor cells (RPCs) and otic placode
In the retina, Sox9 maintains a multipotent pool of retinal
progenitor cells (RPCs), playing a role similar to that in the
CNS. In multipotent murine RPCs, Sox9 is expressed
throughout retinogenesis, and is continuously expressed in
Muller glial cells into adulthood.65 Sox9 is induced by Notch
signaling during retinal development, and once expressed,
it recruits binding partners such as microphtahlmia-
associated transcription factor (MITF) and OTX2 to main-
tain retinal pigment epithelium (RPE).66,67 During this pro-
cess, another SoxE protein, Sox8, and a SoxB protein, Sox2,
play compensatory roles.68
In inner ear, Sox9 plays essential functions, although its
roles vary among species. In Xenopus and zebrafish, Sox9 is
required for initial specification of the otic placode. A
morpholino antisense oligonucleotide-mediated depletion
of Sox9 in Xenopus results in loss of early otic markers and
failure of otic vesicle development, and overexpression of
Sox9 leads to enlarged or ectopic otic vesicles.13,69 Similarly
in zebrafish, loss of Sox9a and Sox9b results in absence or
severe reduction of the otic vesicle.12 On the other hand, in
mice, Sox9 is not required for initial specification of the otic
placode but instead controls adhesive properties and
invagination of placodal cells.70 Interestingly, covalent
attachment of SUMO to Sox9 by gene fusion inhibits
expression of neural crest markers but increases expression
of markers of inner ear development, suggesting that the
posttranslational SUMOlyation may act as a switch.13involved in epithelial-mesenchymal transition (EMT) for neural
n excess extracellular matrix (ECM) deposition and EMT,25 which
and EMT,12,25,39,40 which implies its role in tumor formation and
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Sox9 in pancreas, liver, and intestine
During embryonic development in mammals, the upper
digestive tract organsdthe liver, pancreas, and duode-
numdare derived from the primitive foregut endoderm, and
share Sox9 expression in their progenitor populations. The
pancreas has two different secretory structuresdendocrine
and exocrinedthat originate from different sources of pro-
genitors.71 Sox9 is necessary for normal pancreas develop-
ment, as pancreas-specific Sox9 depletion result in severe
pancreas hypoplasia.72 In line with abundant cases of
pancreatic endocrine impairments in patients with campo-
melic dysplasia (CD), the endocrine lineage seems to be
more sensitive to Sox9 than the exocrine lineage.73 Experi-
mentally reducing Sox9 gene expression to 50% in mouse
pancreatic progenitors led to a reduction in endocrine pro-
genitors expressing neurogenin 3 (Ngn3), a gene necessary
and sufficient for establishing an endocrine cell fate.74
During this process, Notch/Ngn3/Hes1 signaling regulates
Sox9 in a dose-dependent manner. Too little or too much
Notch results in tight regulation of Sox9: activated Ngn3
downregulates Sox9 expression in the endocrine cell
compartment, and with high Notch activity, the transcrip-
tion factor hairy and enhancer of split-2 (Hes1) represses
Ngn3.75 In exocrine pancreatic development, a similar
mechanism seems to be at work, with pancreas-specific
transcription factor 1a (Ptf1a) substituting for Ngn3.76
Bile ducts are structures within the liver that produce and
secrete bile, and are divided into intrahepatic (within the
liver) or extrahepatic (outside the liver).71 During liver
development, Sox9 is expressed not in hepatocytes, the cells
that secrete bile, but instead in cholangiocytes and mucin-
producing cells that line the extrahepatic bile duct.77
Notably, studies using lineage tracing with Sox9-IRES-Cre
knock-in mice and BAC Sox9-CreER transgenic mice demon-
strated that embryonic Sox9þ cholangiocytes could differ-
entiate into hepatocytes.78,79 Evidence suggests that Sox9
determines the timing of bile duct morphogenesis: after a
maturation step, the biliary tube is entirely composed of
Sox9þ cholangiocytes, and embryonic liver-specific inacti-
vation of Sox9 results in delayed duct maturation.80 In addi-
tion, Notch seems to regulate Sox9 in this process, as seen in
the etiology of Alagille syndrome, a genetic disorder in the
liver, heart, kidney, and other systems of the body caused by
mutations in Notch pathway.81
In normal intestinal epithelium, Sox9 is localized to the
nuclei of crypt cells, including terminally differentiated
Paneth cells, stem cells, and a subset of transit-amplifying
(TA) cells.82 Functionally, Sox9 suppresses proliferation in
mouse intestinal epithelium in vivo, and inactivation of
Sox9 results in increased proliferation.82,83 A recent report
demonstrated that Sox9 regulates insulin-like growth factor
(IGF)-binding protein 4 (IGFBP-4), an inhibitor of the IGF/
IGF-receptor pathway in cell proliferation.84
Sox9 in lung
The discovery of Sox9 expression in bronchial epithelium,
and neonatal deaths of CD patients due to respiratorydistress, first hinted at the significance of Sox9 in lung
development.85 However, there are conflicting results
regarding the role of Sox9 in the lung epithelium. Specific
inactivation of Sox9 in respiratory epithelial cells of the
mouse lung using a doxycycline-inducible Cre/loxP system
leads to normal lung structure, postnatal survival, and
repair following oxygen injury.86 However, other studies
suggest that Sox9 is required for proper lung morphogen-
esis; loss of Sox9 leads to extracellular matrix defects,
cytoskeletal disorganization and aberrant epithelial move-
ment.87,88 Another finding suggests that the role of Sox9 is
crucial in tracheal development, as transgenic mice lacking
Sox9 expression have morphological defects in the trachea,
are unable to breathe, and die at birth.89 These contrasting
reports on Sox9 regulation of lung epithelial lung branching
may be due to the different genetic backgrounds of the
mice.
The roles of Sox9 in adult tissues
To maintain homeostasis of an adult organ, either in the
physiological state or a regenerative state after injury, an
orchestrated mechanism ensures correct cell type and tis-
sue architecture. Sox9 expression during development
continues in adult stem and progenitor cells, and seems to
be crucial in adult tissues. Here, we review recent data
linking Sox9 with adult stem/progenitor cell maintenance
and specification.
Sox9 in ectoderm-derived tissues: NPCs, retina, HF-
SCs, and skin pigmentation
In the CNS, Sox9 continues to play a necessary role in the
maintenance of multipotent NPCs throughout adult life, as
shown by in vivo fate mapping experiments in the adult
subependymal zone and olfactory bulbs.56 In the retina,
Sox9 is crucial for retinogenesis, but continues to maintain
these differentiated Muller glial cells postnatally as a result
of Notch regulation, shown in a conditional knockout
approach.65,67 In addition, Sox9 expression in Muller glial
cells persists in the adult tissues.65
In mature retinal pigment epithelium (RPE) cells, Sox9
acts synergistically with transcription factors orthodenticle
homeobox 2 (OTX2) and the LIM homeobox family (LHX) to
activate visual cycle genes by common miRNAs.90
Epithelial hair follicle stem cells (HF-SCs) reside in the
“bulge” of the outer root sheath (ORS), and are essential
for cyclic bouts of adult hair growth.91 Sox9 is crucial in
maintenance and differentiation of adult skin by HF-SCs;
postnatal conditional ablation of Sox9 results in mice born
with fragile, atrophic hair shafts, suggesting that Sox9 is
expressed by adult HF-SCs in the bulge and also may be
required for their survival.63 Moreover, a recent study with
conditional Sox9 targeting in adult HF-SCs demonstrated
that Sox9 elicits an inhibitory function on epidermal dif-
ferentiation in the SC bulge. While Sox9-defiecent HF-SCs
transition from quiescence to proliferation and launch the
subsequent hair cycle, they differentiate into epidermal
cells rather than remaining as HF-SCs.92
Although many findings position Sox9 in stem cell ho-
meostasis and regeneration during adult life, some
156 A. Jo et al.evidence reveals its role in cell fate specification. One such
case is in skin pigmentation. In Xenopus, along with Sox10,
Sox9 induces NC stem cells to differentiate into melano-
cytes.93 Another finding showed that Sox9 is upregulated by
ultraviolet B exposure in adult and neonatal melanocytes.
This regulation results in activation of microphthalmia-
associated transcription factor, dopachrome tautomerase,
and tyrosinase promoters, all of which contribute to in-
creases in key melanogenic proteins and subsequent
pigmentation.94Sox9 in endoderm-derived tissues: intestines, liver
and pancreas
Developmentally derived Sox9þ progenitors in upper
digestive tract organs from primitive foregutdthe liver,
pancreas, and duodenumdcarry over as imprints into adult
life.71 However, the extent of Sox9’s effects within each
organ varies considerably. While it is well established that
Sox9þ progenitor zone serves as a continuous source of new
tissues intestines, whether it has any physiological function
in the adult liver and pancreas is still debated.
In intestinal epithelium, the most rapidly self-renewing
tissue in adult mammals, a continuous supply of new cells
and elimination of old cells preserves homeostasis at the
top of the intestinal villi.95 In colon epithelium-derived
cells, Sox9 transcriptionally represses the CDX2 and MUC2
genes, normally expressed in the mature villus cells, and
may therefore contribute to the Wnt-dependent mainte-
nance of a progenitor cell phenotype.96 In addition, Sox9 is
required for differentiation of Paneth cells, which reside
adjacent to the crypt’s niche as post-mitotic, differenti-
ated cells, and are important for maintaining epithelial cell
renewal.83 Taken together, Sox9 maintains the homeostasis
of the intestinal epithelium both directly and indirectly.
In adult liver, tamoxifen-related toxicity in lineage
tracing studies has complicated the interpretation of Sox9
expression hepatocytes.79,97 More recently, tamoxifen-
independent tracing experiments argued against physio-
logically functioning progenitors in ducts. They revealed
that hepatocytes labeled with this virus-mediated induc-
tion method were maintained solely through proliferation,
and that Sox9þ duct cells do not participate in maintaining
adult organ homeostasis.98 Interestingly, Sox9þ cells in the
liver can be reprogrammed into insulin-secreting duct cells,
implying that developmentally related cells can be modi-
fied to be used in a potential therapy for diabetes.99
In the adult pancreas, although Sox9 expression persists
throughout the pancreatic ductal tree,79 it is not clear
whether these Sox9þ cells are physiologically active.
Lineage-tracing experiments using BAC Sox9-CreER trans-
genic mice show that Sox9þ duct cells lose their differen-
tiation ability within a few days after birth,100 suggesting
that adult Sox9þ duct cells do not function as stem/pro-
genitor cells. A similar result was obtained from another
lineage-tracing experiment, in which targeted adult ductal
b cells failed to differentiate into functioning acinar/
endocrine cells.101 Moreover, pulse and chase experiments
support the notion that adult pancreatic b cells and acinar
cells are maintained by the self-duplication of preexisting
cells rather than by differentiation from progenitors.115,116Taken together, most of these results refute the existence
of stem/precursor cells in the adult pancreatic duct.
Sox9 in developmental disorders
Campomelic dysplasia (CD)
Campomelic dysplasia (CD) refers to a rare autosomal
dominant skeletal dysmorphology syndrome characterized
by congenital bowing of the limb long bones, a small, bell-
shaped thoracic cage, and hypoplastic scapulae.85 Other
features not related to chondrogenesis include respiratory
deficiencies with softening of the laryngo-tracheal carti-
lages, male-to-female sex reversal in XY patients, and a
variety of congenital heart defects.117 CD is caused by
haploinsufficiency of Sox9 due to deletions or mutations in
or around the Sox9 gene.6,42 Furthermore, disrupting the
homodimerizing capacity of Sox9 has been linked to CD but
not male-to-female sex reversal, indicating that homo-
dimerization of Sox9 is required for proper cartilage for-
mation but not for gonad formation.23
XY gonad dysgenesis
The role of Sox9 in gonad dysgenesis was first speculated
due to a high proportion of male-to-female sex reversals in
XY males with CD, as mentioned above.85 This is logical
considering that Sox9 is downstream of Sry, the gene that
encodes a crucial factor in triggering Sertoli cell develop-
ment. Ectopic expression of Sox9 in the female gonad of XX
mice causes complete female-to-male sex reversal,
demonstrating that Sox9 is sufficient to trigger testis dif-
ferentiation in the absence of Sry.118
Hypertrichosis and alopecia areata
Sox9 has been implicated in hereditary disorders of hair
growth. Hypertrichosis is a rare syndrome defined as
excessive hair growth in a particular body area that is not
hormone dependent.119 Evidence suggests that Trps1, a
gene associated with hypertrichosis in mice and humans,
directly represses Sox9, and the absence of this gene ac-
tivity results in premature proliferation of HF-SCs.120 In a
family with a history of hypertrichosis, a copy number
variation upstream of Sox9 showed decreased expression of
HF genes.120 On the other end of the spectrum is alopecia
areata, a condition that causes characteristic patches of
hair loss.121 In mice, skin-specific knockout of Sox9 leads to
the loss of hair shaft stem cells and causes similar bald
patches.
Sox9 in acquired diseases
Sox9 in fibrosis, sclerosis and related disorders
One of the common characteristics among fibrosis, sclerosis,
and related disorders is excessive, inappropriate extracel-
lular matrix (ECM) deposition, and subsequent destruction
of tissue architecture and function in response to injury.122
Considering its role in ECM deposition, evidenced in
Sox9 in development and diseases 157chondrogenesis, it seems logical that Sox9 has been impli-
cated in the pathology of fibrotic diseases (Fig. 4B).
When damage occurs in the liver, a Sox9-dependent
process causes hepatic stellate cells (HSCs) to proliferate
into myofibroblasts, migrate to the surrounding paren-
chymal cells, and secrete ECM components for repair. In
human fetal hepatocytes, aberrant induction of Sox9 cau-
ses ectopic expression of genes that encode the ECM com-
ponents, Col2a1 and Comp1, which are normally expressed
during chondrogenesis. Inducing transforming growth fac-
tor-b (TGF-b) signaling in activated HSCs leads to Sox9
expression, and causes type1 collagen production.123
Moreover, in vivo experiments using culture-activated
HSCs posited Sox9 as a critical regulator of Osteopontin
(OPN), an ECM component that is a biomarker for the
severity of liver fibrosis. However, the same study also
suggested that it is Hedgehog signaling, not TGF-b, that lies
upstream of Sox9.35
In the kidney, high Sox9 expression is correlated with
glomeruloscelerosis. A microarray gene expression profiling
diseased glomeruli showed strongly upregulated expression
of Sox9.124 In addition, highly elevated expressions of OPN
and other TGF-b pathway-related genes were observed,
suggesting that Sox9 activity is similar in both glomer-
uloscelerosis and liver fibrosis.124 In keeping with this
finding, Sox9 appears to function downstream of TGF-b1 to
activate Col4a2 transcription in mesangial cells, the
specialized cells that surround blood vessels in the kidney.125Sox9 in tumorigenesis and cancer
Dysregulation of tissue differentiation pathways and stem
cell homeostasis can contribute to the development and
progression of cancer. Sox9 has been implicated in the
formation and growth of tumors in prostate, the CNS, skin,
pancreas, ovary, and esophagus.126e135 It seems logical that
the role of Sox9 in controlling progenitor cells, to either
proliferate or differentiate during development and adult
life, could actually promote neoplasia if dysregulated
(Fig. 4C).
Studies in human and mice place Sox9 as a key player in
prognosis of prostate cancers. In phosphatase and tensin
homolog (PTEN)þ/ mice, overexpression of Sox9 in adult
mouse prostate epithelia induces an early high-grade
prostate intraepithelial neoplasia (PIN) lesion, indicating
that Sox9 augments the loss of PTEN to promote disease.136
Furthermore, Sox9 levels are found to be increased in
advanced lesions of human prostate cancer, and over-
expression of Sox9 in LNCaP prostate cancer xenografts
enhances growth, angiogenesis, and tumor invasion.134,137
One possible mechanism by which Sox9 functions here is
by trans-activating the androgen receptor, as some pros-
tate cancers are androgen-dependent.135 However, one
study showed that Sox9 suppresses growth and tumorigen-
esis in the prostate tumor cell line M12.127
Sox9 is also implicated in nervous system tumors. In
glioma cell lines, siRNA knockdown of Sox9 reduced cell
proliferation in vitro.132 In vivo, Sox9 production is
increased in malignant nerve sheath tumors, and repressing
this expression by small hairpin RNA causes cell death in
culture.129In skin, Sox9 is expressed in basal cell carcinomas, and is
detected in over 80% of melanomas.130,133 Sox9 is thought
to lie downstream of Sonic hedgehog (Shh) and Gli2 tran-
scription factor both of which have been implicated in skin
tumors.63,138,139 However, another study demonstrated an
inhibitory function of Sox9 in melanomas, as vector-derived
Sox9 in both melanoma cell lines and xenografts decreased
cell proliferation and tumor growth by direct upregulation
of the cell cycle arrest gene, p21.130
In the pancreatic ductal system, clinical adenoma and
carcinoma samples showed Sox9 overexpression localized
to the bottom part of the crypts, suggesting that dysregu-
lation of stem cell homeostasis may be responsible.131 In
addition, Sox9 accelerates the formation of precursor le-
sions of pancreatic ductal adenocarcinoma (PDA) when co-
expressed with a PDA-initiating Kras mutation.140 In ade-
nocarcinomas, a potential NF-kB binding site was found in
the Sox9 promoter with NF-kB subunits up-regulating Sox9
expression, indicating that Sox9 is epigenetically regulated
by NF-kB signaling pathway.108
Taken together, these data present opposing roles for
Sox9 in tumors, either inducing or potentially inhibiting cell
proliferation. It should be kept in mind that the difference
between these studies could be attributed, in part, to the
differences in cell lines and levels of Sox9. These factors
should be controlled for in future experiments.Concluding remarks and future directions
Most insight into the biological properties of Sox9 has come
from developmental studies, particularly involving chon-
drogenesis and male gonad genesis. Recent molecular and
functional analyses of Sox9 have documented an additional
role in stem cell biology of mesoderm-, ectoderm-, and
endoderm-derived tissues and organs. While Sox9 maintains
adult stem and progenitor cells with high turnover, as in
intestine and hair follicles, it is also crucial for postnatal
injury repair in endodermic and ectodermic organs. Iden-
tifying partner factors, signaling pathways, and post-
transcriptional modifications have provided a better
understanding of Sox9’s versatility in different tissues and
at different stages in mammalian life. The availability of
appropriate mouse models and the ability to maintain rare
stem cell populations in culture, combined with genome-
wide technologies, should now enable researchers to
further address fundamental questions at the mechanistic
level.
In human diseases, mutations in Sox9 can cause birth
defects in skeletal deformity, male-to-female sex re-
versals, and hair growth, and has been implicated in fibrosis
and cancer. In addition, recent findings regarding fibrosis
and cancer correlate Sox9 with developmental roles in cell
proliferation, extracellular matrix (ECM) deposition, and
epithelial-to-mesehchymal (ETM) transition. However,
conflicting results position Sox9 with opposing roles in
tumorigenesis, as evidenced in melanoma studies. These
discrepancies may be due to the differences in individual
cancer cell lines or mouse models, with further investiga-
tion being warranted.
Immunostaining for Sox9 carries prognostic value in a
wide range of tumors, including neurofibromatosis,
158 A. Jo et al.meduloblastoma, pancreatic cancer, and protstate cancer,
and can aid in diagnosis. Moreover, Sox9 can be a potential
target for novel therapeutic intervention that might
compensate for the current lack of effective anti-fibrotic
therapies and cancer treatments. However, Sox9 expression
in many tissue types complicates cell-specific effects,
which is why investigating this protein’s diverse mecha-
nisms and pathways is so important. Another challenge of
using Sox9 therapeutically is modulating transcription fac-
tor levels. One potential way of reducing Sox9 could be to
use small peptides or neutralizing antibodies to modify its
function and expression. The manipulation of Sox9 levels
might also be possible indirectly by modulating key mole-
cules involved in upstream signaling pathways, such as TGF-
b1, Wnt, and Hh signaling, all three of which have been
linked to cancer and fibrosis.
In summary, accumulating evidence implicates Sox9 in
pluripotent and multipotent stem cell biology and tissue
regeneration, in addition to its role in cell fate decisions. A
better understanding of the mechanisms by which Sox9
induces and maintains these stem cell populations should
provide important insights into how tissue stem cells are
regenerated and maintained, and might lead to new stra-
tegies for treating degenerative diseases and cancer.
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